Breathe Well Live Well
|
A Competitive Analysis of the Global Asthma and COPD Therapeutics Market …
MarketWatch oBenralizumab, a monoclonal antibody jointly being developed by MedImmune and AstraZeneca in Phase 3 trials. Benralizumab is bound to the interleukin-5 receptor (IL-5R?) and is being evaluated to help asthma control and reduce the onset of asthmatic … |
View full post on asthma – Google News
|
American Lung Association and WellPoint Collaborate to Help Educate About …
MarketWatch According to the Centers for Disease Control and Prevention, asthma is a common, potentially life threatening condition, affecting more than seven million children in the U.S. It is a prevalent issue in our nation's schools. In a typical classroom of … |
View full post on asthma – Google News
|
The Asthma Market Is Forecast to Remain Stable over the Next Decade, Despite …
MarketWatch BURLINGTON, Mass., Oct. 8, 2014 /PRNewswire/ — Decision Resources Group finds that the market for asthma will remain stable, increasing slightly from $15.1 billion in 2013 to $16.1 billion in 2023 in the United States, France, Germany, Italy, Spain … |
View full post on asthma – Google News
|
PharmaPoint: Asthma – Japan Drug Forecast and Market Analysis to 2023
MarketWatch Asthma accounts for approximately 250,000 deaths around the world annually, deaths that otherwise could be easily prevented through appropriate treatment The asthma market saw very slow growth over the past decade, as it has become saturated with … |
View full post on asthma – Google News
|
PharmaPoint: Asthma – US Drug Forecast and Market Analysis to 2023
MarketWatch Asthma accounts for approximately 250,000 deaths around the world annually, deaths that otherwise could be easily prevented through appropriate treatment The asthma market saw very slow growth over the past decade, as it has become saturated with … |
View full post on asthma – Google News
|
PharmaPoint: Asthma – 5EU Drug Forecast and Market Analysis to 2023
MarketWatch Asthma accounts for approximately 250,000 deaths around the world annually, deaths that otherwise could be easily prevented through appropriate treatment The asthma market saw very slow growth over the past decade, as it has become saturated with … |
View full post on asthma – Google News
|
Asthma Drug Market 2023 Forecasts: US, 5EU & Japan Industry Analysis
MarketWatch According to Asthma – 5EU Drug Forecast and Market Analysis to 2023 research report covering the UK, France, Italy, Spain, Germany, the 2013 base-year market sales of asthma products in France were $918m.The relatively slow growth of the German … Fostair Asthma Market Forecast Analysis in recent report |
View full post on asthma – Google News
|
Arches Health Plan launches mobile health app from Symptomly: Asthma …
MarketWatch In the United States there are currently over 25 million Asthmatics, or 1 in every 12 people is suffering from Asthma. Of those, 2.1 million will be admitted to a hospital or emergency room this year. The estimated medical costs for asthmatics patients … |
View full post on asthma – Google News
|
Global Asthma Market 2014-2018
MarketWatch Asthma is a disease that affects the lungs and is characterized by wheezing, coughing, breathlessness, and chest tightness. It is a chronic ailment of the respiratory tract, which is caused by the obstruction of the flow of air and bronchospasms, where … Journal of Pediatrics study shows U.S. schools unprepared for student asthma … |
View full post on asthma – Google News
|
New Study Shows Asthma & Allergy Sufferers Can Help Reduce Airborne …
MarketWatch To help reduce exposure to allergy and asthma triggers, many patients implement lifestyle changes, such as washing bedding frequently, using hypo-allergenic pillow cases and HEPA vacuum cleaners, and using high-efficiency air filters in forced heating … |
View full post on asthma – Google News